Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Biotechnology Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Protein Engg Meet 2023

ABOUT CONFERENCE

Conference Series would like to announce “7th International Conference on Protein Engineering” June 19-20, 2023 London, UK use this opportunity to extend an invitation to you all. The conference will examine recent developments and fresh approaches in the fields of protein and genetic engineering.

Participants can learn a great deal about advancements in research fields outside of their own because to the Congress's breadth and extensive subject covering. Additionally, a variety of special workshops tries to keep attendees interested in bigger topics, like teaching in proteomics research.

The focus of PROTEIN ENGG MEET 2023 will be firmly on encouragement and support for the following Young Researchers Forum, early-career researchers, and events to promote conversation with peers and authorities are all included.

 

TARGET AUDIENCE

Laboratory for Protein and Genetic Research Heads

Researchers \sPractitioners

Doctors \sScientists

health professionals

Nutritionists/Dieticians

Physicians

Health care experts

Professors

Students

Research Centers

Corporate delegates

Young Academics

Executives of advertising and promotion agencies

Professionals working in the media

Medical schools

Pharmaceutical and medical businesses

Medical equipment & businesses

Healthcare experts

Agents or representatives of management or business

Government or non-government organisations, 

 

Sessions and Tracks

TRACK 1: Protein Engineering

Protein engineering is the process of developing beneficial or marketable proteins, and research is conducted towards understanding processes and recognising requirements for protein dietary guidelines. Analysts will receive more in-depth instruction on a variety of topics, including protein in vitro development, aspects of biocatalysis, advancements in protein design for biocatalysis, protein engineered biomaterials, and more. The development of manufactured science, building useful biocatalysts, and computational protein engineering are some often used themes in protein design. By 2020, it is predicted that the protein engineering market would grow at a CAGR of 15.7% and reach $1,463.0 million. In the United States, there are very nearly 3000 people working in protein engineering from 60–65 institutions. There are also a few meetings and workshops, such as ones for biomolecular designing.

Track 2: Protein Folding

Protein folding is the quick and repeatable physical process by which a protein chain develops its native 3-dimensional structure, a shape that is typically biologically useful. Since a few years ago, scientists have continued to investigate the myriad mechanisms, forces at work, and processes involved in protein folding.

 TRACK3: Genetic Engineering

The use of genetic engineering methods in enzyme technology is known as enzyme engineering. The production and kinetics of the enzyme, the structure of the enzymes, and many other characteristics can be enhanced or changed by genetic engineering. De novo design, next-generation sequencing and protein engineering combined, rational modification of enzyme function, combinatorial enzyme engineering, and enzyme and biosensor engineering are some of the topics covered. Enzyme Engineering employs over 4000 employees from 75 colleges in the USA.

Track 4 : Enzyme Engineering

Catalyst engineering is the practise of using gene-splicing methods in catalyst technology. A variety of factors, including the assembly and dynamics of the catalyst, the structure of the enzymes, the Diamond State novo design, the intersection of supermolecule engineering and next-generation sequencing, the rational modification of catalyst function, combinatorial catalyst engineering, and catalyst and biosensor engineering, can also improve or alter gene splicing.

Track 5: Protein Engineered Biomaterials

Growth factors are readily available, and knowledge of bone regeneration is growing. New techniques for tissue-engineering applications have been developed as a result, including recombinant signalling molecules, solid free-form scaffold fabrication, synthetic cartilage, electrochemical deposition, spinal fusion, and ossification. Nanomedicines, Cell interactions with Nanoparticles, Revolutionary Opportunities and Future Possibilities of Nanotechnology, Bio-nanotechnology, Biomedical Nanotechnology, Tissue Growing Nanostructures, Nano-Mechanisms for Molecular Systems, Nano-Bio-Computing, Biomedical Application of Nanoparticles and Functional Nanomaterials, and Deviational Nanotechnology are some of the most important aspects of Biomedical Engineering research.

The enzymes' atomic structure

DENOVO DESIGN

Track 6: Structure and Function of Proteins

The three-dimensional arrangement of atoms in Associate in nursing amino acid-chain molecule is macromolecule structure. Polymers square measure proteins that specifically polypeptides and square measure fashioned from sequences of amino acids, and monomers of the compound. The structure of macromolecules has impact|a bearing|a control|a sway} on their perform to the extent is shown by the effect of changes within the structure of a protein. as well as slight amendments within the folding and form of the macromolecule might render it non-functional once any change in macromolecule at any structural level.

  • Protein structure databases
  • Protein Sequence Analysis
  • Protein structure determination
  • Protein folding

Track 7: Genomics & Structural Genomics

Genetics is the study of an organism's complete genome, taking elements from genetic science into consideration. Genetics uses a combination of DNA, deoxyribonucleic acid sequencing techniques, and bioinformatics to sequence, assemble, and analyse the structure and functionality of genomes.

  • Medical genetics and molecular science
  • Functional genetics
  • Structural genetics
  • Epigenomics

Genomic science is the branch of genetics that deals with the description of ordering structures. This knowledge may be aided by the practise of modifying a species' genes and deoxyribonucleic acid segments.

  • Modelling Threading
  • logical databases
  • Bioinformatics using structures
  • conventional structural forecasting

Track 8:  Protein Engineered Biomaterials

Modern techniques for tissue engineering applications with the expansion factors convenience and also the increasing content regarding the bone generation include recombinant communication molecules, scaffolds of solid free morpheme fabrication, artificial gristle, chemical deposition, fusion, and ossification. The most comprehensive study on the use of nanotechnology in medicine, tissue engineering, nanomedicines, cell interactions with nanoparticles, revolutionary opportunities and future risks of engineering science, bio-nanotechnology in medicine, tissue growing nanostructures, nano-mechanics for molecular systems, nano-bio-computing, medical specialty application of nanoparticles, and practical nanomaterials and devices for medical s.

  • Biomedical engineering uses biomaterials
  • Biomaterial-protein interactions
  • Technology and design for biomaterials

Track 9: Proteomics in Plant & Animal

Each protein-based living cell is dynamic, sterilising in response to its metabolic state and the reception of internal and extracellular signal molecules. Many of the expressed proteins have post-translational modifications. Since the purpose of protein analysis is to aid in the comprehension and interaction of the super molecule, it is necessary to identify the proteins in their final form. Identification of individual proteins by mass spectrometric analysis is crucial for identifying websites and types of medications.

  • The proteomics of gels
  • rapid proteomics
  • tolerance for salinity
  • Late-Embryogenesis Abundant (LEA) Proteins from Photosynthesis

Track 10 : Pharmacogenomics & Pharmacoproteomics

Pharmacogenomics is the study of the impact that order plays in medication response. Its name is a reflection of the blending of genetics and medicine. Pharmacogenomics examines how a person's genetic make-up influences how they respond to drugs.

Pharmacoproteomics is a rapidly developing discipline where genetics approaches are used to create pharmacological drugs. Personalized medicine is important in this area of research. Genetics is the full complement of proteins that an organism or tissue expresses at a given moment and under certain conditions. The whole collection of proteins used in the study will serve as a substitute for significantly more sophisticated pharmacodynamics assays at a lower cost in terms of time, financial output, and clinical risk.

  • enzymatic metabolizers of drugs
  • Implementation of clinical prediction
  • Polypharmacy

Track 11: Mass Spectrometry in Proteome Research

Macromolecule mass qualitative analysis is the application of mass qualitative analysis to the study of proteins. Protein characterization is an essential emerging tool for mass qualitative analysis. Two-dimensional gel ionophoresis, which produces cellular macromolecule maps and gives a quantitative and qualitative view of the protein, is frequently used. Mass qualitative analysis is the method of choice for the rapid, extensive identification of those proteomes and their modifications. Proteogenomics uses the mass qualitative analysis knowledge to experimentally confirm sequence product and support ordination annotation and comparison.

  • Electrospray ionization mass spectrometry (ESI-MS)
  • Matrix-Assisted laser desorption (MALDI-TOF-MS)
  • Liquid chromatography mass spectrometry (LC-MS)
  • Technology for multidimensional protein identification
  • Identification and verification of prot

Track 12: Transcriptome analysis & Gene Expression

Transcriptase and organic phenomena should be discussed first because they are important issues. It can be accomplished by learning the right facts about how rRNA, transfer RNA, and template RNA operate. Organic phenomenon analysis experiments might centre on a set of pertinent target genes. The location of factors and the relative distances between genes on a body can be identified by sequence mapping. Even in the absence of reference ordering, transcriptome can be generated using Delaware novo transcriptome assembly approach.

  • stem cell and cancer cell transcriptomes
  • The function of small interfering RNA (siRNA) and micro RNA (mi RNA) ( si RNA)
  • mRNA, tRNA, and rRNA activity
  • Cancer development and cellular differentiation
  • serial gene expression analysis
  • Profiling of the transcriptome and proteome
  • gene transcription

TRACK 13: Antibodies: Medical Applications

Antibodies are frequently utilised in a variety of diagnostic methods. Immunoassay is the word used to describe diagnostic procedures based on antibodies. The most popular confirmatory diagnostic assays are antibody-based immunoassays, which are also one of the fastest-growing biomolecule analysis technologies. Advances in test specificity, detection methods, and sensitivity are seen in trends in antibody-based diagnostics. Depending on whether the antigen to be measured competes with the labelled antigen for a finite number of antibody binding sites, sensitivity and specificity are guaranteed. Today, monoclonal antibodies are widely employed in therapy, clinical diagnostic procedures, and all branches of biological and medical research. This review focuses on the therapeutic application of antibodies in therapy, especially in light of the characteristics ofthe antibodies that seem to be most important to their utility. The significance of the antibody isotype and valency for antigen as well as the specificity of binding have been shown in in vitro experiments employing human effector systems and in vivo animal models.

Track 14: Antibody Drug Therapy

Conventional cancer treatments frequently lack specificity, which leads to toxicities to healthy normal tissues and a low therapeutic index. A cytotoxic drug is chemically joined to an antibody (Ab) that identifies a tumor-associated antigen in antibody-drug conjugates (ADCs), a therapeutic approach. ADC technology works by combining the power of cytotoxic agents, such as specific natural products and synthetic compounds, with the target selectivity of mAbs in order to create therapeutic medications that are both extremely effective and secure. Currently, the ADC platform offers a wide variety of cytotoxic payloads, linker technologies, and conjugation techniques. More than 30 ADCs are now in clinical development, and two recently got FDA approval. This gathering intends to showcase developments in ADC.

Track 14: Cancer Genome Biology

Cancer genomics uses genome sequencing and bioinformatics to examine the genetic changes responsible for disease. Understanding which characteristics and quality communications affect various subsets of growths is key to using cancer genomics to improve tumour treatment. The Global Cancer Genome Consortium (ICGC) is a purposeful exploratory organisation that promotes collaboration among the top genomic researchers in the world. This following track covers topics including genetic characteristics of cancer, protein markers, cancer functional genomics and epigenomics, bioinformatics & systems biology of cancer, big data, and genome medicine.

Track 15: Regenerative Medicine

The practise of replacing, altering, or regenerating human cells, tissues, or organs in order to restore or establish normal function is known as   and it is a subfield . The most recent discoveries in regenerative medicine research include improvements in dental and craniofacial regeneration, molecular treatment, cell and gene therapy, and stem cell research. The potential of regenerative therapies to heal, replace, and regenerate tissues and organs that have been damaged by an injury, a disease, or the natural ageing process is unmatched. These drugs are effective at making cells and tissues functional again. By 2020, the market for regenerative medicine will be worth $67.6 billion, up from $16.4 billion in 2013. This represents a CAGR of 23.2% over the forecast period (2014 - 2020).

Track 16: Protein Folding

Protein folding is the quick and repeatable physical process by which a protein chain develops its native 3-dimensional structure, a shape that is typically biologically useful. Researchers have been working on solving the puzzle of the various mechanisms, pressures, and processes involved in protein folding for the past few years.

Track 17 :Protein Crystallography

Protein crystallography uses extremely high-resolution microscopy to examine protein structures at the atomic level, which aids in understanding how proteins operate. Designing new medications that target a specific protein or enzyme that can be employed in industrial processes has heavily relied on protein crystallography.

Track 18: Protein Therapeutics & Market Analysis

The different uses and resources for Protein Therapeutics and Market Analysis include Protein Biomarkers, Protein Gold Standards, Recombinant Protein Drugs, Protein Expression Services and Market Analysis, and Fusion Protein Therapeutics. Although it is still in its infancy, protein therapies are already playing a key role in practically every area of medicine.

Track 19: Molecular Modelling and Drug Designing

A important and necessary tool for molecular modelling in the drug style     method is now medical chemists. Within molecular modelling, molecules  with three-dimensional structures are chosen for production, manipulation,  or illustration together with the related physio-chemical properties.

  • ·Applications And Principles Of Molecular Modeling
  • ·Software for molecular design and the Monte Carlo approach for molecular graphics
  • ·drug creation
  • ·design of retrometabolic drugs

Track 20 : Bioinformatics and Computational Biology

The machine way developments and applications are useful for analysing biological knowledge such as genetic sequences, samples of supermolecules, or cell populations, for creating new hypotheses, or for making recent biological discoveries, which is a knowledge domain field in both machine biology and bioscience. Machine methods use analytical approaches, mathematical modelling, and simulation.

  • Machine learning and data mining
  • Computer-aided anatomy
  • Machine intelligence
  • Computer-based biomodeling

 

To Collaborate Scientific Professionals around the World

Conference Date June 19-20, 2023

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by